Authors: Haya, S Lopez, MF Aznar, JA Batlle, J

Citation: S. Haya et al., Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry, HAEMOPHILIA, 7(2), 2001, pp. 154-159

Authors: Cid, AR Lorenzo, JI Haya, S Montoro, JM Casana, P Aznar, JA

Citation: Ar. Cid et al., A comparison of FVII : C and FVIIa assays for the monitoring of recombinant factor VIIa treatment, HAEMOPHILIA, 7(1), 2001, pp. 39-41

Authors: Casana, P Martinez, F Haya, S Espinos, C Aznar, JA

Citation: P. Casana et al., Association of the 3467C > T mutation (T1156M) in the von Willebrand's factor gene with dominant type 1 von Willebrand's disease, ANN HEMATOL, 80(7), 2001, pp. 381-383

Authors: Casana, P Martinez, F Haya, S Tavares, A Aznar, JA

Citation: P. Casana et al., New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease, HAEMATOLOG, 86(4), 2001, pp. 414-419

Authors: Casana, P Martinez, F Haya, S Lorenzo, JI Espinos, C Aznar, JA

Citation: P. Casana et al., Q1311X: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene, BR J HAEM, 111(2), 2000, pp. 552-555

Authors: Casana, P Martinez, F Haya, S Aznar, JA

Citation: P. Casana et al., Identification of a new candidate mutation, G1629R, in a family with type 2A von Willebrand disease, AM J HEMAT, 60(4), 1999, pp. 309-310